Market Overview

Benzinga's Top Downgrades

Share:
Benzinga's Top Downgrades
Related THOR
Thoratec Shareholders Approve St. Jude Medical's Acquisition Of Thoratec
Thoratec Announces HeartMate 3 CE Mark Trial Met Primary Endpoint
Related LOW
3 Ways To Build An Election-Proof Portfolio
Lowe's Investors Finding Attractive Price To Build Their Position
Lowe's Is Cheaper Than Home Depot, Why? (Seeking Alpha)

Analysts at Goldman Sachs downgraded Thoratec (NASDAQ: THOR) from “buy” to “neutral.” The target price for Thoratec has been lowered from $42 to $37. Thoratec's shares closed at $32.60 on Friday.

Analysts at Oppenheimer downgraded Lowe's Companies (NYSE: LOW) from “outperform” to “perform.” The target price for Lowe's is set to $46. Lowe's shares closed at $42.67 on Friday.

Analysts at Keefe Bruyette & Woods downgraded Bank of America (NYSE: BAC) from “outperform” to “perform.” Bank of America's shares closed at $13.43 on Friday.

Jefferies downgraded Bed Bath & Beyond (NASDAQ: BBBY) from “buy” to “hold.” The target price for Bed Bath & Beyond has been lowered from $76 to $71. Bed Bath & Beyond's shares closed at $69.11 on Friday.

Latest Ratings for THOR

DateFirmActionFromTo
Sep 2015BMO CapitalUpgradesMarket PerformOutperform
Aug 2015Raymond JamesDowngradesOutperformMarket Perform
Aug 2015Leerink SwannDowngradesOutperformMarket Perform

View More Analyst Ratings for THOR
View the Latest Analyst Ratings

Posted-In: Top DowngradesDowngrades Analyst Ratings

 

Related Articles (BBBY + BAC)

View Comments and Join the Discussion!